Autocrine activation of human monocyte/macrophages by monocyte‐derived microparticles and modulation by PPARγ ligands
Open Access
- 11 July 2011
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 165 (3), 716-728
- https://doi.org/10.1111/j.1476-5381.2011.01593.x
Abstract
BACKGROUND AND PURPOSE Microparticles (MPs), small membrane-bound particles originating from different cell types during activation or apoptosis, mediate intercellular communication, exert pro-coagulant activity and affect inflammation and other pathophysiological conditions. Monocyte-derived MPs have undergone little investigation and, to our knowledge, have never been evaluated for their possible autocrine effects. Therefore, we assessed the ability of monocyte-derived MPs to stimulate human monocytes and monocyte-derived macrophages (MDM). EXPERIMENTAL APPROACH MPs were generated from supernatants of human monocytes stimulated by the calcium ionophore A23187 (12 µM), and then characterized. Human monocytes and MDM of healthy donors were isolated by standard procedures. Cells were challenged by MPs or phorbol 12-myristate 13-acetate (PMA, used as standard stimulus), in the absence or presence of PPARγ agonists and antagonists. Superoxide anion production (measured spectrophotometrically), cytokine release (elisa), PPARγ protein expression (immunoblotting) and NF-κB activation (EMSA assay) were evaluated. KEY RESULTS Monocyte-derived MPs induced, in a concentration-dependent manner, oxygen radical production, cytokine release and NF-κB activation in human monocytes and macrophages, with lower effects than PMA. In both cell types, the PPARγ agonists rosiglitazone and 15-deoxy-Δ12,14-prostaglandin J2 (15d-PGJ2) inhibited MPs-induced stimulation and this inhibition was reversed by a PPARγ antagonist. In human monocyte/macrophages, MPs as well as rosiglitazone and 15d-PGJ2 induced PPARγ protein expression. CONCLUSION AND IMPLICATIONS In human monocyte/macrophages, monocyte-derived MPs exert an autocrine activation that was modulated by PPARγ ligands, inducing both pro-inflammatory (superoxide anion production, cytokine release and NF-κB activation) and anti-inflammatory (PPARγ expression) effects.This publication has 47 references indexed in Scilit:
- Microparticles From Human Atherosclerotic Plaques Promote Endothelial ICAM-1–Dependent Monocyte Adhesion and Transendothelial MigrationCirculation Research, 2011
- Tobacco Smoke Induces the Generation of Procoagulant Microvesicles From Human Monocytes/MacrophagesArteriosclerosis, Thrombosis, and Vascular Biology, 2010
- HDL Interfere with the Binding of T Cell Microparticles to Human Monocytes to Inhibit Pro-Inflammatory Cytokine ProductionPLOS ONE, 2010
- Tobacco smoke affects expression of peroxisome proliferator-activated receptor-γ in monocyte/macrophages of patients with coronary heart diseaseBritish Journal of Pharmacology, 2009
- A novel activity for substance P: stimulation of peroxisome proliferator‐activated receptor‐γ protein expression in human monocytes and macrophagesBritish Journal of Pharmacology, 2008
- Peroxisome proliferator-activated receptor γ and retinoid X receptor transcription factors are released from activated human platelets and shed in microparticlesThrombosis and Haemostasis, 2008
- Quantification of PPAR-γ protein in monocyte/macrophages from healthy smokers and non-smokers: A possible direct effect of nicotineLife Sciences, 2007
- Microparticles as regulators of inflammation: Novel players of cellular crosstalk in the rheumatic diseasesArthritis & Rheumatism, 2005
- A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-γNature, 2005
- The release of microparticles by apoptotic cells and their effects on macrophagesApoptosis, 2005